Signaling pathways
-
BA5453 5-LOX-IN-6Summary: 5-LOX-IN-6 is a directly reversible inhibitor. - BA5454 CAY10583Summary: CAY10583 is a potent and selective full leukotriene B4 receptor type 2 (BLT2) agonist.
- BA5455 BMS-986278Summary: BMS-986278 is a potent and orally active hemophosphatidic acid receptor 1 antagonist with values of 6.9 nM and 4.0 nM for human and mouse LPA1, respectively.
- BA5456 BMS-986020Summary: BMS-986020 (AM152) is a high affinity lysophosphatidic acid receptor 1 antagonist.
- BA5457 SLF1081851Summary: SLF1081851 is an inhibitor that suppresses release (=1.93 μM).
- BA5458 EtrasimodSummary: Etrasimod (APD334) is a highly potent selective and orally active receptor antagonist.
- BA5459 CAY10444Summary: CAY10444 (BML-241) is an antagonist.
- BA5460 CYM50358Summary: CYM50358 is a potent and selective antagonist.
- BA5461 AS2717638Summary: AS2717638 is an orally bioactive, selective antagonist.
- BA5462 GSK2018682Summary: GSK2018682 is an agonist.